231 related articles for article (PubMed ID: 27650493)
1. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
[TBL] [Abstract][Full Text] [Related]
2. Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers.
Liba Z; Nohejlova H; Capek V; Krsek P; Sediva A; Kayserova J
PLoS One; 2019; 14(7):e0219987. PubMed ID: 31356620
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of CXCL8, CXCL10 and Th1 /Th2 cytokines in the serum and cerebrospinal fluid of patients with neurosyphilis].
Yu XY; Yan N; Li ZH; Chen W; Hua YH; Lu Y
Zhonghua Nan Ke Xue; 2020 Apr; 26(4):335-340. PubMed ID: 33351301
[TBL] [Abstract][Full Text] [Related]
4. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE).
Zajkowska J; Moniuszko-Malinowska A; Pancewicz SA; Muszyńska-Mazur A; Kondrusik M; Grygorczuk S; Swierzbińska-Pijanowska R; Dunaj J; Czupryna P
Adv Med Sci; 2011; 56(2):311-7. PubMed ID: 22008312
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis.
Li D; Huang X; Shi M; Luo L; Tao C
Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504
[TBL] [Abstract][Full Text] [Related]
7. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis.
Moniuszko A; Czupryna P; Pancewicz S; Rutkowski K; Zajkowska O; Swierzbińska R; Grygorczuk S; Kondrusik M; Owłasiuk P; Zajkowska J
Immunol Lett; 2014; 157(1-2):45-50. PubMed ID: 24239846
[TBL] [Abstract][Full Text] [Related]
9. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
[TBL] [Abstract][Full Text] [Related]
10. Has CXCL13 an added value in diagnosis of neurosyphilis?
Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
[TBL] [Abstract][Full Text] [Related]
11. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
[TBL] [Abstract][Full Text] [Related]
12. Increased CCL24 and CXCL7 levels in the cerebrospinal fluid of patients with neurosyphilis.
Li XX; Zhang J; Wang ZY; Chen SQ; Zhou WF; Wang TT; Man XY; Zheng M
J Clin Lab Anal; 2020 Sep; 34(9):e23366. PubMed ID: 32419252
[TBL] [Abstract][Full Text] [Related]
13. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.
Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ
BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P
J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218
[TBL] [Abstract][Full Text] [Related]
16. The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.
Dersch R; Hottenrott T; Senel M; Lehmensiek V; Tumani H; Rauer S; Stich O
Fluids Barriers CNS; 2015 May; 12():12. PubMed ID: 25975424
[TBL] [Abstract][Full Text] [Related]
17. Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study.
Han BK; Kuzin I; Gaughan JP; Olsen NJ; Bottaro A
Arthritis Res Ther; 2016 Apr; 18():93. PubMed ID: 27102921
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV.
Carvalho RS; Rangel IC; Soane MM; Bacarov NBS; Herbst V; Ferry FRA
AIDS; 2024 Apr; 38(5):657-668. PubMed ID: 38079581
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.
Marra CM
Sex Transm Dis; 2021 Aug; 48(8S):S54-S57. PubMed ID: 33967236
[TBL] [Abstract][Full Text] [Related]
20. The potential for CXCL13 in CSF as a differential diagnostic tool in central nervous system infection.
Masouris I; Klein M; Ködel U
Expert Rev Anti Infect Ther; 2020 Sep; 18(9):875-885. PubMed ID: 32479125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
